TRVI financials
Trevi Therapeutics (TRVI) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
TRVI income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | -$49.33M | -$42.76M | -0.29 |
| 2024 | $0.00 | $0.00 | -$51.52M | -$47.91M | -0.47 |
| 2023 | $0.00 | $0.00 | -$33.92M | -$29.07M | -0.29 |
| 2022 | $0.00 | $0.00 | -$29.91M | -$29.15M | -0.45 |
| 2021 | $0.00 | $0.00 | -$32.48M | -$33.94M | -1.49 |
| 2020 | $0.00 | -$47.00K | -$32.49M | -$32.76M | -1.81 |